These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2616378)

  • 1. Single dose pharmacokinetics of calcium antagonist nifedipine in ethanol dependent rats.
    Siembab D; Janicki PK
    Pol J Pharmacol Pharm; 1989; 41(3):219-21. PubMed ID: 2616378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study.
    Boje KM; Dolce JA; Fung HL
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):219-26. PubMed ID: 6515116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: induction of rat hepatic P-450 by grapefruit juice.
    Mohri K; Uesawa Y; Sagawa Ki
    Drug Metab Dispos; 2000 Apr; 28(4):482-6. PubMed ID: 10725318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog.
    Tokuma Y; Fujiwara T; Niwa T; Hashimoto T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):249-62. PubMed ID: 2711027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of m-nifedipine in rabbits after intravenous injection.
    Ma J; Xie JW; Jia ZP; Song L; Xu SY; Zhao DH
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):109-11. PubMed ID: 9772655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.
    Boje KM; Fung HL
    J Pharmacol Exp Ther; 1989 May; 249(2):567-71. PubMed ID: 2724140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
    Ahr HJ; Krause HP; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1099-104. PubMed ID: 3196403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations in the pharmacokinetics, tissue distribution and urinary excretion of nifedipine after a single oral administration to rats.
    Cao QR; Kim TW; Choi JS; Lee BJ
    Biopharm Drug Dispos; 2005 Dec; 26(9):427-37. PubMed ID: 16217814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of benidipine hydrochloride in rats and dogs.
    Kobayashi H; Kobayashi S; Inoue A; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1750-3. PubMed ID: 3219154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium antagonists on central actions of ethanol: comparative studies with nifedipine, verapamil and cinnarizine.
    Czarnecka E; Kubik-Bogucka E
    Alcohol Alcohol; 1993 Nov; 28(6):649-55. PubMed ID: 8147973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine kinetics and dynamics in hypertensive patients: a new approach.
    Akopov SE; Sarkissian MA; Grigorian GS; Panossian AG
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):317-20. PubMed ID: 7921534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine.
    Daniel W; Syrek M; Janczar L; Boksa J
    Pol J Pharmacol; 1995; 47(2):127-36. PubMed ID: 8688885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Second communication: distribution and elimination of the new monoclonal antibody, regavirumab after repeated administration in rats, and placental transfer and milk-passage study after single administration to pregnant and lactating rats.
    Ishii S; Arizono H; Nagao T; Kudo S; Kondo S; Kiyoki M
    Arzneimittelforschung; 1994 Jul; 44(7):899-908. PubMed ID: 7945530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute and chronic ethanol administration on the transport of thiamine from plasma to different brain regions of the rat.
    Patrini C; Reggiani C; Laforenza U; Rindi G
    Alcohol Alcohol; 1988; 23(6):455-63. PubMed ID: 3245865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.